These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8030842)
1. alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trial. Barbagallo Sangiorgi G; Barbagallo M; Giordano M; Meli M; Panzarasa R Ann N Y Acad Sci; 1994 Jun; 717():253-69. PubMed ID: 8030842 [TBL] [Abstract][Full Text] [Related]
2. A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia. Di Perri R; Coppola G; Ambrosio LA; Grasso A; Puca FM; Rizzo M J Int Med Res; 1991; 19(4):330-41. PubMed ID: 1916007 [TBL] [Abstract][Full Text] [Related]
3. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. Parnetti L; Amenta F; Gallai V Mech Ageing Dev; 2001 Nov; 122(16):2041-55. PubMed ID: 11589921 [TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial. Salvadori E; Poggesi A; Donnini I; Rinnoci V; Chiti G; Squitieri M; Tudisco L; Fierini F; Melone A; Pescini F; Pantoni L Drugs Aging; 2021 Jun; 38(6):481-491. PubMed ID: 33855653 [TBL] [Abstract][Full Text] [Related]
11. Dl-3-n-butylphthalide can improve the cognitive function of patients with acute ischemic stroke: a prospective intervention study. Yan H; Yan Z; Niu X; Wang J; Gui Y; Zhang P Neurol Res; 2017 Apr; 39(4):337-343. PubMed ID: 28145815 [TBL] [Abstract][Full Text] [Related]
12. [An experimental, randomized, double-blind, placebo-controlled clinical trial to infestigate the effect of nicardipine on cognitive function in patients with vascular dementia. Spanish group of nicardipine study in vascular dementia]. Rev Neurol; 1999 May 1-15; 28(9):835-45. PubMed ID: 10390744 [TBL] [Abstract][Full Text] [Related]
13. Citicoline in vascular cognitive impairment and vascular dementia after stroke. Alvarez-Sabín J; Román GC Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R; Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516 [TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Tianmabianchunzhigan in mild to moderate vascular dementia: Protocol of a randomized controlled IIa trial. Tian J; Shi J; Wei M; Li T; Ni J; Zhang X; Zhang M; Li Y; Wang Y Medicine (Baltimore); 2018 Dec; 97(51):e13760. PubMed ID: 30572524 [TBL] [Abstract][Full Text] [Related]
17. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results. Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283 [TBL] [Abstract][Full Text] [Related]
18. Serial montreal cognitive assessments demonstrate reversible cognitive impairment in patients with acute transient ischemic attack and minor stroke. Sivakumar L; Kate M; Jeerakathil T; Camicioli R; Buck B; Butcher K Stroke; 2014 Jun; 45(6):1709-15. PubMed ID: 24757105 [TBL] [Abstract][Full Text] [Related]
19. Late treatment with choline alfoscerate (l-alpha glycerylphosphorylcholine, α-GPC) increases hippocampal neurogenesis and provides protection against seizure-induced neuronal death and cognitive impairment. Lee SH; Choi BY; Kim JH; Kho AR; Sohn M; Song HK; Choi HC; Suh SW Brain Res; 2017 Jan; 1654(Pt A):66-76. PubMed ID: 27765578 [TBL] [Abstract][Full Text] [Related]
20. Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial. Moniche F; Escudero I; Zapata-Arriaza E; Usero-Ruiz M; Prieto-León M; de la Torre J; Gamero MA; Tamayo JA; Ochoa-Sepúlveda JJ; Maestre J; Carmona M; Piñero P; Calderón-Cabrera C; Jimenez MD; Gonzalez A; Montaner J Int J Stroke; 2015 Oct; 10(7):1149-52. PubMed ID: 26044701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]